KCNMB3
Gene Overview <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">KCNMB3</th> </tr> <tr> <td class="label">Symbol </td> <td>KCNMB3</td> </tr> <tr> <td class="label">Full Name </td> <td>Potassium Calcium-Activated Channel Subfamily M Regulatory Beta Subunit 3</td> </tr> <tr> <td class="label">Chromosome </td> <td>22q12.1</td> </tr> <tr> <td class="label">NCBI Gene </td> <td>[8912](https://www.ncbi.nlm.nih.gov/gene/8912)</td> </tr> <tr> <td class="label">UniProt </td> <td>[Q9NS88](https://www.uniprot.org/uniprot/Q9NS88)</td> </tr> <tr> <td class="label">Ensembl </td> <td>[ENSG00000143001](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143001)</td> </tr> <tr> <td class="label">Protein Length </td> <td>281 amino acids</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~31 kDa</td> </tr> <tr> <td class="label">Condition</td> <td>Evidence</td> </tr> <tr> <td class="label">Epilepsy</td> <td>Genetic association studies</td> </tr> <tr> <td class="label">Migraine</td> <td>GWAS signals near KCNMB3 locus</td> </tr> <tr> <td class="label">Cerebellar ataxia</td> <td>Channel dysfunction</td> </tr> <tr> <td class="label">Neuropathic pain</td> <td>Peripheral nerve involvement</td> </tr> <tr> <td class="label">Partner</td> <td>Interaction Type</td> </tr> <tr> <td class="label">KCNMA1</td> <td>Channel assembly</td> </tr
...
KCNMB3
Gene Overview <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">KCNMB3</th> </tr> <tr> <td class="label">Symbol </td> <td>KCNMB3</td> </tr> <tr> <td class="label">Full Name </td> <td>Potassium Calcium-Activated Channel Subfamily M Regulatory Beta Subunit 3</td> </tr> <tr> <td class="label">Chromosome </td> <td>22q12.1</td> </tr> <tr> <td class="label">NCBI Gene </td> <td>[8912](https://www.ncbi.nlm.nih.gov/gene/8912)</td> </tr> <tr> <td class="label">UniProt </td> <td>[Q9NS88](https://www.uniprot.org/uniprot/Q9NS88)</td> </tr> <tr> <td class="label">Ensembl </td> <td>[ENSG00000143001](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143001)</td> </tr> <tr> <td class="label">Protein Length </td> <td>281 amino acids</td> </tr> <tr> <td class="label">Molecular Weight </td> <td>~31 kDa</td> </tr> <tr> <td class="label">Condition</td> <td>Evidence</td> </tr> <tr> <td class="label">Epilepsy</td> <td>Genetic association studies</td> </tr> <tr> <td class="label">Migraine</td> <td>GWAS signals near KCNMB3 locus</td> </tr> <tr> <td class="label">Cerebellar ataxia</td> <td>Channel dysfunction</td> </tr> <tr> <td class="label">Neuropathic pain</td> <td>Peripheral nerve involvement</td> </tr> <tr> <td class="label">Partner</td> <td>Interaction Type</td> </tr> <tr> <td class="label">KCNMA1</td> <td>Channel assembly</td> </tr> <tr> <td class="label">KCNMB1</td> <td>Heteromerization</td> </tr> <tr> <td class="label">KCNMB2</td> <td>Co-assembly</td> </tr> <tr> <td class="label">RGS proteins</td> <td>Regulation</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
{{.infobox .infobox-gene}}
Introduction KCNMB3 encodes the beta 3 subunit (KCNMB3) of large-conductance calcium-activated potassium (BK) channels[@kcnmb2000]. BK channels are widely expressed in various tissues including brain, smooth muscle, and endocrine cells, where they play crucial roles in regulating neuronal excitability, neurotransmitter release, and vascular tone[@channels2019]. The beta subunits modulate channel gating properties, trafficking, and pharmacological responses[@beta2001].
Molecular Function
BK Channel Biology The BK channel (also known as Slo1 or KCa1.1) is a voltage-gated potassium channel with high conductance (100-200 pS) that is activated by both membrane depolarization and intracellular calcium[@structure2008]. The channel consists of four alpha subunits (encoded by KCNMA1) that form the pore, together with optional beta and gamma auxiliary subunits that modify channel properties.
Beta 3 Subunit Specificity KCNMB3 (beta 3) is one of four beta subunit isoforms (beta 1-4) that confer distinct properties to BK channels:
Modulation of gating : Beta 3 subunits shift the voltage dependence of activation and alter calcium sensitivity[@beta2003]
Tissue-specific expression : KCNMB3 is expressed in brain, testis, and certain endocrine tissues
Alternative splicing : Multiple splice variants generate functional diversity
Pharmacological modulation : Beta subunit composition influences sensitivity to channel blockers and activators[@channel2012]
Role in the Brain
Neuronal Excitability In [neurons](/entities/neurons), BK channels regulate:
Action potential repolarization and firing patterns
Calcium-dependent afterhyperpolarization
Neurotransmitter release at synaptic terminals
Response to excitatory and inhibitory stimuli[@channels2015]
Expression Patterns KCNMB3 is expressed in:
Cerebral [cortex](/brain-regions/cortex) (pyramidal neurons)
[Hippocampus](/brain-regions/hippocampus) (CA1-CA3 regions)
Basal ganglia
Cerebellum (Purkinje cells)
Sensory neurons[@regional2006]
Neurological Implications
Neuroprotection BK channel activation has been implicated in neuroprotection through several mechanisms:
Reduction of neuronal calcium overload
Attenuation of excitotoxicity
Modulation of mitochondrial function
Regulation of oxidative stress responses[@channel2017]
Channelopathies Dysregulation of BK channel function is associated with:
Epilepsy and seizure disorders
Migraine
Cerebellar ataxia
Neurodevelopmental disorders[@channel2018]
Disease Associations
Neurological Disorders While KCNMB3 is not a primary disease-causing gene, variations in BK channel complex genes have been linked to:
Cardiovascular Implications Given beta subunit expression in vascular smooth muscle:
Hypertension associations
Cerebral vasodilation regulation
Stroke risk modulation[@channels2014]
Therapeutic Targeting
BK Channel Modulators Drugs targeting BK channels are under development for:
Activators : BMS-204352,NS11021 - potential neuroprotective agents
Blockers : Iberiotoxin, paxilline - research tools
Clinical Trials Several trials explore BK channel modulators for:
Stroke and traumatic brain injury
Migraine prophylaxis
Smooth muscle disorders[@channel2020]
Genetics
Gene Structure The KCNMB3 gene spans approximately 8 kb on chromosome 22q12.1 and contains:
Multiple exons with alternative splicing
Promoter region with tissue-specific regulatory elements
Variants
Single nucleotide polymorphisms (SNPs) studied in neurological phenotypes
Copy number variations involving the 22q12.1 region
No known pathogenic mutations causing monogenic disease[@genetic2016]
Model Systems
Knockout mice : Kcnmb3 knockout mice show altered BK channel properties
Zebrafish models : Used to study channel subunit assembly
In vitro expression : HEK293 and CHO cells for functional studies
Antibodies
Commercial antibodies available for protein detection
Immunohistochemistry for tissue localization[@antibody2014]
Interactions
See Also
BK channels
[Potassium channels](/mechanisms/potassium-channel-dysfunction)
[KCNMA1](/genes/kcnma1)
[Ion channel genes](/content/genes)
[Neuroprotection](/mechanisms/neuroprotection)
External Links
[NCBI Gene: KCNMB3](https://www.ncbi.nlm.nih.gov/gene/8912)
[UniProt: Q9NS88](https://www.uniprot.org/uniprot/Q9NS88)
[Ensembl: ENSG00000143001](https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143001)
[IUPHAR: BK channel](https://www.guidetopharmacology.org/GRAC/receptorDisplayForward?receptorId=1569)
References
[Unknown, KCNMB3: a calcium-activated potassium channel beta subunit. (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/10633462/))
[Unknown, BK channels in neuronal function. (2019) (2019)](https://pubmed.ncbi.nlm.nih.gov/31141647/))
[Unknown, Beta subunit modulation of BK channels. (2001) (2001)](https://pubmed.ncbi.nlm.nih.gov/11579258/))
[Unknown, Structure and function of BK channels. (2008) (2008)](https://pubmed.ncbi.nlm.nih.gov/18563187/))
[Unknown, Beta3 subunit specifically modulates BK channels. (2003) (2003)](https://pubmed.ncbi.nlm.nih.gov/12770941/))
[Unknown, BK channel pharmacology and beta subunits. (2012) (2012)](https://pubmed.ncbi.nlm.nih.gov/22453228/))
[Unknown, BK channels in synaptic transmission. (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26289573/))
[Unknown, Regional distribution of BK channel beta subunits in brain. (2006) (2006)](https://pubmed.ncbi.nlm.nih.gov/16631225/))
[Unknown, BK channel activation and neuroprotection. (2017) (2017)](https://pubmed.ncbi.nlm.nih.gov/28315661/))
[Unknown, BK channel mutations in neurological disease. (2018) (2018)](https://pubmed.ncbi.nlm.nih.gov/29953851/))
[Unknown, BK channels in cardiovascular disease. (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24907583/))
[Unknown, BK channel modulators in clinical development. (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32869215/))
[Unknown, Genetic variation in KCNMB3 and neurological traits. (2016) (2016)](https://pubmed.ncbi.nlm.nih.gov/27550747/))
[Unknown, Antibody validation for BK channel subunits. (2014) (2014)](https://pubmed.ncbi.nlm.nih.gov/24824544/))
Show full description